Pharmacological validation of candidate causal sleep genes identified in an N2 cross
about
Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor SystemA systems approach identifies networks and genes linking sleep and stress: implications for neuropsychiatric disorders.Computationally efficient permutation-based confidence interval estimation for tail-area FDR
P2860
Pharmacological validation of candidate causal sleep genes identified in an N2 cross
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pharmacological validation of candidate causal sleep genes identified in an N2 cross
@ast
Pharmacological validation of candidate causal sleep genes identified in an N2 cross
@en
Pharmacological validation of candidate causal sleep genes identified in an N2 cross
@nl
type
label
Pharmacological validation of candidate causal sleep genes identified in an N2 cross
@ast
Pharmacological validation of candidate causal sleep genes identified in an N2 cross
@en
Pharmacological validation of candidate causal sleep genes identified in an N2 cross
@nl
prefLabel
Pharmacological validation of candidate causal sleep genes identified in an N2 cross
@ast
Pharmacological validation of candidate causal sleep genes identified in an N2 cross
@en
Pharmacological validation of candidate causal sleep genes identified in an N2 cross
@nl
P2093
P2860
P1476
Pharmacological validation of candidate causal sleep genes identified in an N2 cross
@en
P2093
Alan T Savitz
Andrea L Webber
Anthony L Gotter
Fred Turek
Jacquelyn Binns
John J Renger
Joseph I Brunner
Joseph R Owens
Joshua Millstein
P2860
P304
P356
10.3109/01677063.2011.628426
P407
P577
2011-12-01T00:00:00Z